CIK: 0001802528
Total reported value
$1.4B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | COGT | Cogent Biosciences INC | Stock-Other | 24.34% | -9.04% | — | |
| 2 | APGE | Apogee Therapeutics INC | Stock-Other | 11.77% | -9.95% | — | |
| 3 | SYRE | Spyre Therapeutics INC | Stock-Other | 10.02% | +4.62% | — | |
| 4 | VRDN | Viridian Therapeutics INC | Stock-Other | 9.27% | -3.74% | +13.14% | |
| 5 | ORKA | Oruka Therapeutics INC | Stock-Other | 8.55% | +4.58% | — | |
| 6 | DNTH | Dianthus Therapeutics INC | Stock-Other | 6.70% | +8.68% | -35.38% | |
| 7 | ZBIO | Zenas Biopharma INC | Stock-Other | 6.11% | -2.78% | +16.71% | |
| 8 | NUVL | Nuvalent Inc-a | Stock-Other | 5.57% | -5.57% | EXIT | |
| 9 | JBIO | Jade Biosciences INC | Stock-Other | 5.35% | -0.73% | +41.40% | |
| 10 | ELVN | Enliven Therapeutics INC | Stock-Other | 4.35% | +0.90% | — | |
| 11 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 4.14% | -4.14% | EXIT | |
| 12 | ✓ | Crescent Biopharma INC. | Stock-Other | 2.48% | +1.17% | +97.99% | |
| 13 | IKT | Inhibikase Therapeutics INC | Stock-Other | 1.35% | -0.30% | +40.82% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | COGT | Cogent Biosciences INC | +12.7% | — | Unchanged |
| 2 | APGE | Apogee Therapeutics INC | +4.5% | — | Unchanged |
| 3 | SYRE | Spyre Therapeutics INC | +4% | — | Unchanged |
| 4 | JBIO | Jade Biosciences INC | +2.9% | +41.40% | Add |
| 5 | VRDN | Viridian Therapeutics INC | +2.6% | +13.14% | Add |
| 6 | ZBIO | Zenas Biopharma INC | +2.3% | +16.71% | Add |
| 7 | ORKA | Oruka Therapeutics INC | +2.1% | — | Unchanged |
| 8 | ✓ | Crescent Biopharma INC. | +1% | +97.99% | Add |
| 9 | IKT | Inhibikase Therapeutics INC | +0.5% | +40.82% | Add |
| 10 | NUVL | Nuvalent Inc-a | -0.1% | — | Unchanged |
| 11 | KNSA | Kiniksa Pharmaceuticals International, plc | -2.1% | -25.56% | Trim |
| 12 | ELVN | Enliven Therapeutics INC | -2.5% | — | Unchanged |
| 13 | DNTH | Dianthus Therapeutics INC | -5% | -35.38% | Trim |
| 14 | AXSM | Axsome Therapeutics INC | — | EXIT | Sold out |
| 15 | SRRK | Scholar Rock Holding CORP | — | EXIT | Sold out |
| 16 | ABVX | Abivax Sa-adr | — | EXIT | Sold out |
| 17 | CATBUSD | Astria Therapeutics INC | — | EXIT | Sold out |